Mineralys Therapeutics | 8-K: Mineralys Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Mineralys Therapeutics | 8-K: Current report
Mineralys Therapeutics | 8-K: Current report
Mineralys Therapeutics | 8-K: Mineralys Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Mineralys Therapeutics | 8-K: Current report
Mineralys Therapeutics | 8-K: Current report
Mineralys Therapeutics | 8-K: Current report
Mineralys Therapeutics | 8-K: Current report
Mineralys Therapeutics | 8-K: Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Mineralys Therapeutics | DEFA14A: Others
Mineralys Therapeutics | DEF 14A: Definitive information statements
Mineralys Therapeutics | 8-K: Current report
Mineralys Therapeutics | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)
Mineralys Therapeutics | 8-K: Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Mineralys Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Mineralys Therapeutics | 8-K: Current report
Mineralys Therapeutics | 8-K: Current report
Mineralys Therapeutics | 8-K: Current report
Mineralys Therapeutics | 8-K: Current report
Mineralys Therapeutics | 8-K: Mineralys Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
No Data
No Data